These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37165519)

  • 41. Immortal Ozurdex: A 10-month follow-up of an intralenticular implant.
    Poornachandra B; Kumar VBM; Jayadev C; Dorelli SH; Yadav NK; Shetty R
    Indian J Ophthalmol; 2017 Mar; 65(3):255-257. PubMed ID: 28440260
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Accidental injections of dexamethasone intravitreal implant (Ozurdex) into the crystalline lens.
    Coca-Robinot J; Casco-Silva B; Armadá-Maresca F; García-Martínez J
    Eur J Ophthalmol; 2014; 24(4):633-6. PubMed ID: 24519506
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of sustained-release long-acting intravitreal dexamethasone implant in patients of non-proliferative diabetic retinopathy undergoing phacoemulsification: A randomized controlled trial.
    Gupta PC; Ram J; Kumar MP; Agarwal A; Gupta V; Singh R; Bansal R; Katoch D; Dogra MR; Gupta A
    Indian J Ophthalmol; 2021 Nov; 69(11):3263-3272. PubMed ID: 34708785
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and Safety of Intravitreal Dexamethasone Implants for Treatment of Refractory Diabetic Macular Edema.
    Unsal E; Eltutar K; Sultan P; Erkul SO; Osmanbasoglu OA
    Korean J Ophthalmol; 2017 Apr; 31(2):115-122. PubMed ID: 28367039
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Same-Day Bilateral Intravitreal Dexamethasone Implants for the Treatment of Diabetic Macular Edema.
    Lin TC; Tseng PC; Hsu TK; Huang HW; Huang YM; Lo WJ; Chao CY; Chung YC
    Ophthalmologica; 2023; 246(3-4):238-244. PubMed ID: 37552956
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recommendations for the management of diabetic macular oedema with intravitreal dexamethasone implant: A national Delphi consensus study.
    Kodjikian L; Baillif S; Couturier A; Creuzot-Garcher C; Delyfer MN; Matonti F; Weber M
    Eur J Ophthalmol; 2022 Sep; 32(5):2845-2856. PubMed ID: 34779302
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and tolerability of bilateral sustained-release dexamethasone intravitreal implants for the treatment of noninfectious posterior uveitis and macular edema secondary to retinal vein occlusion.
    Ryder SJ; Iannetta D; Bhaleeya SD; Kiss S
    Clin Ophthalmol; 2015; 9():1109-16. PubMed ID: 26150689
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of ranibizumab versus dexamethasone for macular oedema following retinal vein occlusion: 1-year results of the COMRADE extension study.
    Feltgen N; Hattenbach LO; Bertelmann T; Callizo J; Rehak M; Wolf A; Berk H; Eter N; Lang GE; Pielen A; Schmitz-Valckenberg S; Quiering C; Rose U; Hoerauf H;
    Acta Ophthalmol; 2018 Dec; 96(8):e933-e941. PubMed ID: 29855153
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The impact of intravitreal dexamethasone implant (Ozurdex®) on retrobulbar hemodynamics in patients with diabetic macular edema and retinal vein occlusions.
    Gok M; Altas H; Kapti HB
    Cutan Ocul Toxicol; 2019 Sep; 38(3):240-248. PubMed ID: 30773934
    [No Abstract]   [Full Text] [Related]  

  • 50. Effectiveness and Safety of Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema: A Real-World Experience.
    Mello Filho P; Andrade G; Maia A; Maia M; Biccas Neto L; Muralha Neto A; Moura Brasil O; Minelli E; Dalloul C; Iglicki M
    Ophthalmologica; 2019; 241(1):9-16. PubMed ID: 30408801
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Baseline SD-OCT characteristics of diabetic macular oedema patterns can predict morphological features and timing of recurrence in patients treated with dexamethasone intravitreal implants.
    Eandi CM; De Geronimo D; Giannini D; Polito MS; Tosi GM; Neri G; Le Mer Y; Varano M; Parravano M
    Acta Diabetol; 2020 Jul; 57(7):867-874. PubMed ID: 32114643
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intravitreal fluocinolone acetonide implant for the treatment of persistent post-surgical cystoid macular edema in vitrectomized eyes.
    Miguel-Escuder L; Olate-Pérez Á; Sala-Puigdoners A; Moll-Udina A; Figueras-Roca M; Navarro-Angulo MJ; Adán A; Pelegrín L
    Eur J Ophthalmol; 2023 Jan; 33(1):NP23-NP27. PubMed ID: 34836464
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and safety of dexamethasone intravitreal implant for refractory macular edema in children.
    Lei S; Lam WC
    Can J Ophthalmol; 2015 Jun; 50(3):236-41. PubMed ID: 26040225
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intraoperative dexamethasone intravitreal implant in diabetic macular edema patients undergoing phacoemulsification: The CataDex study.
    Vadalà M; Trapani VS; Amato M; Bongiovanni G; Alaimo F; Cillino S; Bonfiglio VME
    Eur J Ophthalmol; 2022 Sep; 32(5):2760-2770. PubMed ID: 34878320
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema.
    Mehta H; Hennings C; Gillies MC; Nguyen V; Campain A; Fraser-Bell S
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011599. PubMed ID: 29669176
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dexamethasone intravitreal implant at the time of cataract surgery in eyes with diabetic macular edema.
    Panozzo GA; Gusson E; Panozzo G; Dalla Mura G
    Eur J Ophthalmol; 2017 Jun; 27(4):433-437. PubMed ID: 28009415
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.
    Haller JA; Bandello F; Belfort R; Blumenkranz MS; Gillies M; Heier J; Loewenstein A; Yoon YH; Jacques ML; Jiao J; Li XY; Whitcup SM;
    Ophthalmology; 2010 Jun; 117(6):1134-1146.e3. PubMed ID: 20417567
    [TBL] [Abstract][Full Text] [Related]  

  • 58. REAL WORLD STUDY COMPARING PHAKIC VERSUS PSEUDOPHAKIC EYES IN DIABETIC MACULAR EDEMA TREATED WITH DEXAMETHASONE IMPLANT: The PHAKIDEX Study.
    Mathis T; Rezkallah A; Ricard C; Vartin C; Abukhashabah A; Devin F; Kodjikian L
    Retina; 2023 Jul; 43(7):1088-1096. PubMed ID: 36977332
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Short-term safety of dexamethasone implant for treatment of macular edema due to retinal vein occlusion, in eyes with glaucoma or treated ocular hypertension.
    Theodoropoulou S; Ellabban AA; Johnston RL; Cilliers H; Mohamed Q; Sallam AB
    Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):725-732. PubMed ID: 27878430
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Efficiency of Intravitreal Dexamethasone Implants in the Treatment of Macular Edema Secondary to Retinal Vein Occlusion.
    Unsal E; Eltutar K; Sultan P; Gungel H
    J Ocul Pharmacol Ther; 2015; 31(6):350-6. PubMed ID: 26133058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.